Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 10:24 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2929–2952 of 145,503 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Disorders Clear all

Conditions: Mild Cognitive Impairment
Interventions: Water-based Activity + Cognitive Training; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 90 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Hepatitis C
Interventions: TT-034; Drug
Lead sponsor: Tacere Therapeutics, Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 4
States / cities: San Diego, California • Durham, North Carolina • Dallas, Texas + 1 more

Conditions: Herpes Labialis, Herpes Simplex Virus
Interventions: Glutamine, Glycine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Post Stroke Pain
Interventions: Transcutaneous Auricular Neurostimulation; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 80 Years
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 2
States / cities: Charleston, South Carolina

Conditions: Prostate Cancer
Interventions: Vitamin E, Selenium, Vitamin E placebo, selenium placebo; Drug · Other
Lead sponsor: SWOG Cancer Research Network; Network
Eligibility: 50 Years to 120 Years · Male only
Enrollment: 35,533 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2012
U.S. locations: 13
States / cities: Chicago, Illinois • Joliet, Illinois • Maywood, Illinois + 8 more

Conditions: Gestational Diabetes, Pregnancy Related
Interventions: Observational; Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2,179 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2025
U.S. locations: 9
States / cities: New Haven, Connecticut • Honolulu, Hawaii • Chicago, Illinois + 5 more

Conditions: Renal Cancer, Kidney Cancer
Interventions: Ultrasound with intravenous microbubble contrast injection; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 21 Years to 99 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: New York, New York

Conditions: Xerostomia, Graft-versus-host-disease, Sjogren's Disease
Interventions: Mesenchymal Stromal Cells (MSC) Dose Level 0, Mesenchymal Stromal Cells (MSC) Dose Level 1; Biological
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Breast Cancer
Interventions: Stereoscopic Digital Mammography; Procedure
Lead sponsor: Emory University; Other
Eligibility: Female only
Enrollment: 1,467 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2011
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Urinary Retention, Urinary Bladder, Neurogenic, Intermittent Catheterization
Interventions: C3 "UMBRELLA CATHETER"; Device
Lead sponsor: Dr. Gaines W. Hammond Jr. MD FACS; Individual
Eligibility: 21 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Lakeland, Florida

Conditions: Osteoarthritis
Interventions: PainCOACH; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 113 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 2
States / cities: Durham, North Carolina • Smithfield, North Carolina

Conditions: Traumatic Brain Injury, Stroke
Interventions: MyoPro Motion-G, Motor Learning-Based Therapy; Device · Other
Lead sponsor: Northwestern University; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Schizophrenia
Interventions: Bifeprunox; Drug
Lead sponsor: Wyeth is now a wholly owned subsidiary of Pfizer; Industry
Eligibility: 18 Years to 66 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 83
States / cities: Little Rock, Arkansas • Anaheim, California • Boynton Beach, California + 67 more

Conditions: Blepharitis
Interventions: Tobradex ST, Azasite; Drug
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Enrollment: 122 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 1
States / cities: Andover, Massachusetts

Conditions: Depression, Anxiety, PTSD, Trauma, Psychological
Interventions: Mindfulness based intervention; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 19 Years to 35 Years
Enrollment: 43 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Cardiovascular Diseases, Cardiovascular Risk Factor, Obesity
Interventions: Mediterranean diet, Olive oil and mixed nuts, American Heart Association; Behavioral · Dietary Supplement
Lead sponsor: Auburn University; Other
Eligibility: 19 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Diabetes Mellitus, Type 1
Interventions: Islet Cell Transplantation; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2010
U.S. locations: 1
States / cities: New York, New York

Conditions: Drinking, Alcohol
Interventions: Advice, Self-monitoring, Feedback; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 25 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Ovarian Cancer, Non-small Cell Lung Cancer
Interventions: TUB-040, Bevacizumab; Drug
Lead sponsor: Gilead Sciences; Industry
Eligibility: 18 Years and older
Enrollment: 334 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 13
States / cities: Birmingham, Alabama • Atlanta, Georgia • Boston, Massachusetts + 10 more

Conditions: Epilepsy in Children, Dyskinesias, Movement Disorders in Children, Neurologic Disorder, Chorea, Myoclonus, Ataxia, Epilepsy, Dystonia Disorder, Movement Disorders
Interventions: Not listed
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 0 Years to 18 Years
Enrollment: 500 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: HIV Infections
Interventions: Network leader training, Standard HIV risk-reduction counseling; Behavioral
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: 18 Years and older
Enrollment: 852 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Mild Cognitive Impairment, Dementia, Alzheimer Disease
Interventions: SSRI; Drug
Lead sponsor: Ohio State University; Other
Eligibility: 50 Years and older
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Epilepsy in Children, Executive Dysfunction
Interventions: Epilepsy Journey web-based modules, Telehealth with a therapist; Behavioral
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 13 Years to 17 Years
Enrollment: 310 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 3
States / cities: Orange, California • Cincinnati, Ohio • Charleston, South Carolina

Conditions: Neurogenic Bladder, Lower Urinary Tract Symptoms, Overactive Bladder, Neuro: Neurogenic Bladder, Neurogenic Detrusor Overactivity
Interventions: Standard number of injection sites, Reduced number of injection sites; Procedure
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Houston, Texas

Search by objective public record fields.

Water-based Activity to Enhance Recall in Veterans

Safety and Efficacy Study of Single Doses of TT-034 in Patients With Chronic Hepatitis C

A Randomized Double-Blind Control-Comparison Crossover Trial of Oral Glutamine to Suppress Frequently Recurrent Herpes Labialis

Post-stroke Pain tAN-fMRI

S0000 Selenium and Vitamin E in Preventing Prostate Cancer

Glycemic Observation and Metabolic Outcomes in Mothers and Offspring

Evaluating Renal Masses Using Ultrasound Intravenous Microbubble Contrast

Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia

An Evaluation of Stereoscopic Digital Mammography for Earlier Detection of Breast Cancer and Reduced Rate of Recall

A Prospective Evaluation of the Catheter Science C3 "Umbrella Catheter."

Internet-Based Osteoarthritis Pain Coping Skills Intervention

Myoelectric Upper Limb Orthosis Use by Persons With TBI and Stroke

Open Label Extension Study of Bifeprunox

A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis

Neural Changes Associated With a Mindfulness-based Intervention for Young Adults With Childhood Maltreatment

A Mediterranean Diet Nutrition Education Program for the Reduction of Cardiovascular Disease Risk in the Southeastern U.S.

Islet Cell Transplants for Diabetes

Multimodal Sleep Intervention Using Wearable Technology

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes

Effectiveness of an HIV Prevention Program That Targets the Inner Workings of High-risk Social Networks

SSRI's and the Rate of Progression From MCI to Dementia

Epilepsy Journey-An Executive Functioning Intervention for Teens With Epilepsy

Optimization of OnabotulinumtoxinA (BTX-A) Injection for the Treatment of Neurogenic Lower Urinary Tract Dysfunction